PER 1.23% 8.0¢ percheron therapeutics limited

the last week in june, page-4

  1. 2,956 Posts.
    lightbulb Created with Sketch. 116
    I look back at PRR that raced to 40cents based

    on CVAC potential - unfortunately PRR has not

    had a lot of things go its way recently. However I look

    at ANP that has 3 potential developments over the next

    6 - 18 months with huge potential - and imo much bigger

    than PRR, if we get a sniff of success in any of these

    Or JV or licence deals this one also has the potential

    to hit similar heights if not more. I know I will be

    smacked down over these comments by some however on face

    value it is hard not to see this one delivering success.

    JMO. GL
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.